Nyra Medical Receives Prestigious Jon DeHaan Foundation Award for Innovation in Cardiology at EuroPCR 2026

▤ Summary

Nyra Medical received the 2026 Jon DeHaan Foundation Award for Cardiovascular Innovation at EuroPCR 2026. The company earned recognition for its CARLEN System, a transcatheter mitral valve repair technology designed to preserve native valve function and expand treatment options for patients with functional mitral regurgitation. The press release highlights early first-in-human clinical results and positions the technology as both clinically differentiated and commercially promising. Nyra also said it will present 12-month outcomes at New York Valves on June 24, 2026, which will add more evidence for broader adoption. The article frames the award as validation of Nyra’s clinical mission and development progress.

▦ Linked Companies